OBJECTIVE: Adverse neurodevelopmental sequelae are common in children with congenital heart defects. Tetralogy of Fallot is part of the clinical phenotype of many genetic syndromes. We evaluated the determinants of neurodevelopmental outcome in patients with tetralogy of Fallot. METHODS: We performed a subgroup analysis of children with tetralogy of Fallot undergoing complete repair before 6 months of age who were enrolled in a trial assessing apolipoprotein E genotype as a predictor of neurodevelopmental outcome. Assessment included genetic evaluation, neurologic examination, and the Bayley Scales of Infant Development-II, yielding the Mental Developmental Index and Psychomotor Developmental Index. RESULTS: Sixty children were tested at 1 year of age. A confirmed or suspected genetic syndrome was identified in 18.3%. The mean Mental Developmental Index was 89 +/- 13, and the mean Psychomotor Developmental Index was 81 +/- 17. Scores for the Mental Developmental Index (76 +/- 13 vs 92 +/- 11) and Psychomotor Developmental Index (63 +/- 13 vs 85 +/- 15) were significantly lower for patients with genetic syndromes. The presence of a genetic syndrome was a predictor of lower Mental Developmental Index and Psychomotor Developmental Index (P = .002 and P = .001). The presence of tetralogy of Fallot with pulmonary atresia and the apolipoprotein E epsilon2 allele were predictive of a lower Mental Developmental Index (P = .001 and P = .035). No other preoperative or operative variables were predictive of worse neurodevelopmental outcome. CONCLUSIONS: At 1 year of age after repair of tetralogy of Fallot, most patients had neurodevelopmental scores within the normal range. Genetic syndromes and the apolipoprotein E epsilon2 allele were important risk factors for neurodevelopmental dysfunction and accounted for some interindividual differences in outcome.
OBJECTIVE: Adverse neurodevelopmental sequelae are common in children with congenital heart defects. Tetralogy of Fallot is part of the clinical phenotype of many genetic syndromes. We evaluated the determinants of neurodevelopmental outcome in patients with tetralogy of Fallot. METHODS: We performed a subgroup analysis of children with tetralogy of Fallot undergoing complete repair before 6 months of age who were enrolled in a trial assessing apolipoprotein E genotype as a predictor of neurodevelopmental outcome. Assessment included genetic evaluation, neurologic examination, and the Bayley Scales of Infant Development-II, yielding the Mental Developmental Index and Psychomotor Developmental Index. RESULTS: Sixty children were tested at 1 year of age. A confirmed or suspected genetic syndrome was identified in 18.3%. The mean Mental Developmental Index was 89 +/- 13, and the mean Psychomotor Developmental Index was 81 +/- 17. Scores for the Mental Developmental Index (76 +/- 13 vs 92 +/- 11) and Psychomotor Developmental Index (63 +/- 13 vs 85 +/- 15) were significantly lower for patients with genetic syndromes. The presence of a genetic syndrome was a predictor of lower Mental Developmental Index and Psychomotor Developmental Index (P = .002 and P = .001). The presence of tetralogy of Fallot with pulmonary atresia and the apolipoprotein E epsilon2 allele were predictive of a lower Mental Developmental Index (P = .001 and P = .035). No other preoperative or operative variables were predictive of worse neurodevelopmental outcome. CONCLUSIONS: At 1 year of age after repair of tetralogy of Fallot, most patients had neurodevelopmental scores within the normal range. Genetic syndromes and the apolipoprotein E epsilon2 allele were important risk factors for neurodevelopmental dysfunction and accounted for some interindividual differences in outcome.
Authors: Sara Piran; Anne S Bassett; Jasmine Grewal; Jodi-Ann Swaby; Chantal Morel; Erwin N Oechslin; Andrew N Redington; Peter P Liu; Candice K Silversides Journal: Am Heart J Date: 2011-01 Impact factor: 4.749
Authors: J William Gaynor; Marsha Gerdes; Alex S Nord; Judy Bernbaum; Elaine Zackai; Gil Wernovsky; Robert R Clancy; Patrick J Heagerty; Cynthia B Solot; Donna McDonald-McGinn; Gail P Jarvik Journal: J Thorac Cardiovasc Surg Date: 2010-10-15 Impact factor: 5.209
Authors: Tiffany Riehle-Colarusso; Andrew Autry; Hilda Razzaghi; Coleen A Boyle; William T Mahle; Kim Van Naarden Braun; Adolfo Correa Journal: Pediatrics Date: 2015-08-17 Impact factor: 7.124
Authors: David C Bellinger; Michael J Rivkin; David DeMaso; Richard L Robertson; Christian Stopp; Carolyn Dunbar-Masterson; David Wypij; Jane W Newburger Journal: Cardiol Young Date: 2014-02-11 Impact factor: 1.093
Authors: William T Mahle; Minmin Lu; Richard G Ohye; J William Gaynor; Caren S Goldberg; Lynn A Sleeper; Victoria L Pemberton; Kathleen A Mussatto; Ismee A Williams; Erica Sood; Catherine Dent Krawczeski; Alan Lewis; Nicole Mirarchi; Mark Scheurer; Sara K Pasquali; Nelangi Pinto; Jeffrey P Jacobs; Brian W McCrindle; Jane W Newburger Journal: Pediatr Cardiol Date: 2012-08-03 Impact factor: 1.655
Authors: Anjali Sadhwani; Lisa A Asaro; Caren Goldberg; Janice Ware; Jennifer Butcher; Michael Gaies; Cynthia Smith; Jamin L Alexander; David Wypij; Michael S D Agus Journal: J Pediatr Date: 2016-04-23 Impact factor: 4.406
Authors: Nancy J Butcher; Eva W C Chow; Gregory Costain; Dominique Karas; Andrew Ho; Anne S Bassett Journal: Genet Med Date: 2012-06-28 Impact factor: 8.822
Authors: John T Berger; Richard Holubkov; Ron Reeder; David L Wessel; Kathleen Meert; Robert A Berg; Michael J Bell; Robert Tamburro; J Michael Dean; Murray M Pollack Journal: J Thorac Cardiovasc Surg Date: 2017-02-10 Impact factor: 5.209
Authors: Stephen A Hart; Ganesh P Devendra; Yuli Y Kim; Scott D Flamm; Vidyasagar Kalahasti; Janine Arruda; Esteban Walker; Thananya Boonyasirinant; Michael Bolen; Randolph Setser; Richard A Krasuski Journal: J Cardiovasc Magn Reson Date: 2013-09-04 Impact factor: 5.364
Authors: Daniel S Kim; Ian B Stanaway; Ramakrishnan Rajagopalan; Judy C Bernbaum; Cynthia B Solot; Nancy Burnham; Elaine H Zackai; Robert R Clancy; Susan C Nicolson; Marsha Gerdes; Deborah A Nickerson; Hakon Hakonarson; J William Gaynor; Gail P Jarvik Journal: PLoS One Date: 2012-09-25 Impact factor: 3.240